Federal Register / Vol. 87, No. 136 / Monday, July 18, 2022 / Notices 42751 

TA–W No. Subject firm Location Inv start date 

98,319 .......... EcoWater Systems LLC ................................................ Woodbury, MN .............................................................. 6/3/2022 

98,320 .......... Otis Worldwide Corporation .......................................... Farmington, CT ............................................................. 6/3/2022 

98,321 .......... Premier Glass USA, LLC .............................................. Park Hills, MO ............................................................... 6/3/2022 

98,322 .......... Eagle’s Catch, LLLP ...................................................... Ellsworth, IA .................................................................. 6/6/2022 

98,323 .......... Massachusetts Mutual Life Insurance Company .......... Springfield, MA .............................................................. 6/6/2022 

98,324 .......... Palisades Power Plant .................................................. Covert, MI ...................................................................... 6/7/2022 

98,325 .......... Aisin Electronics, Inc ..................................................... Stockton, CA ................................................................. 6/10/2022 

98,326 .......... Electronic Arts Inc ......................................................... Austin, TX ...................................................................... 6/13/2022 

98,327 .......... Heartland Construction .................................................. Georgetown, TX ............................................................ 6/13/2022 

98,328 .......... Parkdale Mills Plant #39 ............................................... Alexander City, AL ........................................................ 6/13/2022 

98,329 .......... Kerry Inc ........................................................................ Clark, NJ ........................................................................ 6/14/2022 

98,330 .......... Thule, Inc ....................................................................... Seymour, CT ................................................................. 6/14/2022 

98,331 .......... Tripwire .......................................................................... Portland, OR .................................................................. 6/14/2022 

98,332 .......... Medline Industries, Inc .................................................. Lithia Springs, GA ......................................................... 6/15/2022 

98,333 .......... Parkdale Mills ................................................................ Galax, VA ...................................................................... 6/15/2022 

98,334 .......... SASOL Chemicals (USA) LLC, Oil City Plant, Sasol 

(USA) Corporation.

Oil City, PA .................................................................... 6/15/2022 

98,335 .......... BioReliance Corporation ............................................... Rockville, MD ................................................................ 6/17/2022 

98,336 .......... Imerys Carbonates USA ............................................... Cockeysville, MD ........................................................... 6/17/2022 

98,337 .......... Wells Fargo ................................................................... Frederick, MD ................................................................ 6/17/2022 

98,338 .......... Wisetek Solutions .......................................................... Hyattsville, MD .............................................................. 6/17/2022 

98,339 .......... Boston Scientific Company ........................................... San Jose, CA ................................................................ 6/22/2022 

98,340 .......... Small Wells Vehicle Electronics .................................... Fond du Lac, WI ............................................................ 6/22/2022 

98,341 .......... Advanced Input Systems .............................................. Frankenmuth, MI ........................................................... 6/23/2022 

98,342 .......... R.A. Phillips Industries, Inc ........................................... Santa Fe Springs, CA ................................................... 6/23/2022 

98,343 .......... Prevost Car, Prevost Canada, Volvo Group ................. Plattsburgh, NY ............................................................. 6/23/2022 

98,344 .......... PayPal, Inc .................................................................... LaVista, NE ................................................................... 6/24/2022 

98,345 .......... IEE Sensing, Inc ............................................................ Auburn Hills, MI ............................................................. 6/27/2022 

98,346 .......... Urschel Tool Company .................................................. Cranston, RI .................................................................. 6/28/2022 

98,347 .......... Vestas Towers America, Inc ......................................... Pueblo, CO .................................................................... 6/29/2022 

98,348 .......... Waupaca Foundry, Inc .................................................. Etowah, TN .................................................................... 6/29/2022 

98,349 .......... Medical Component Specialists, Inc ............................. Providence, RI ............................................................... 6/30/2022 

98,350 .......... Michael Food ................................................................. David City, NE ............................................................... 6/30/2022 

98,351 .......... Mitsubishi Electric Automotive America, Inc ................. Maysville, KY ................................................................. 6/30/2022 

98,352 .......... Solar Seal LLC .............................................................. South Easton, MA ......................................................... 6/30/2022 

A record of these investigations and 

petitions filed are available, subject to 

redaction, on the Department’s website 

https://www.dol.gov/agencies/eta/ 

tradeact under the searchable listing or 

by calling the Office of Trade 

Adjustment Assistance toll free at 888– 

365–6822. 

Signed at Washington, DC, this 7th day of 

July 2022. 

Hope D. Kinglock, 

Certifying Officer, Office of Trade Adjustment 

Assistance. 

[FR Doc. 2022–15254 Filed 7–15–22; 8:45 am] 

BILLING CODE 4510–FN–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 50–609; NRC–2013–0235] 

Northwest Medical Isotopes, LLC 

Medical Radioisotope Production 

Facility 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Termination of construction 

permit. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) is terminating the 

Northwest Medical Isotopes, LLC 

(NWMI) Medical Radioisotope 

Production Facility (RPF) construction 

permit (permit) designated as CPMIF– 

002. The permit authorized NWMI to 

construct the RPF in Columbia, 

Missouri. Construction was not initiated 

for the RPF, and nuclear materials were 

never procured or possessed under this 

permit. Consequently, the RPF site is 

approved for unrestricted use. 

DATES: The letter terminating 

Construction Permit No. CPMIF–002 

was issued on July 11, 2022. 

ADDRESSES: Please refer to Docket ID 

NRC–2013–0235 when contacting the 

NRC about the availability of 

information regarding this document. 

You may obtain publicly available 

information related to this document 

using any of the following methods: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2013–0235. Address 

questions about Docket IDs in 

Regulations.gov to Stacy Schumann; 

telephone: 301–415–0624; email: 

Stacy.Schumann@nrc.gov. For technical 

questions, contact the individual listed 

in the FOR FURTHER INFORMATION

CONTACT section of this document. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, 301– 

415–4737, or by email to 

PDR.Resource@nrc.gov. For the 

convenience of the reader, instructions 

about obtaining materials referenced in 

this document are provided in the 

‘‘Availability of Documents’’ section. 

• NRC’s PDR: You may examine and 

purchase copies of public documents, 

by appointment, at the NRC’s PDR, 

Room P1 B35, One White Flint North, 

11555 Rockville Pike, Rockville, 

Maryland 20852. To make an 

appointment to visit the PDR, please 

send an email to PDR.Resource@nrc.gov 

or call 1–800–397–4209 or 301–415– 

4737, between 8:00 a.m. and 4:00 p.m. 

Eastern Time (ET), Monday through 

Friday, except Federal holidays. 

FOR FURTHER INFORMATION CONTACT: 

Michael Balazik, Office of Nuclear 

Reactor Regulation, U.S. Nuclear 


khammond on DSKJM1Z7X2PROD with NOTICES
42752 Federal Register / Vol. 87, No. 136 / Monday, July 18, 2022 / Notices 

Regulatory Commission, Washington, 

DC 20555–0001; telephone: 301–415– 

2856; email: Michael.Balazik@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Introduction 

On May 9, 2018, the NRC issued 

Construction Permit No. CPMIF–002 to 

NWMI to authorize the construction of 

the RPF. Since the issuance of the 

permit, NWMI has not begun 

construction of the RPF or procured 

nuclear materials for use under the 

permit. By letter dated February 7, 2022, 

NWMI stated that the RPF will not be 

constructed and requested that the NRC 

terminate Construction Permit No. 

CPMIF–002. NWMI also stated that no 

physical or principal activities 

authorized by the permit, other than a 

geotechnical survey, were performed at 

the permitted site at Lot 15 of Discovery 

Ridge in Columbia, Missouri. The 

geotechnical survey was required by 

condition 3.G of the permit and 

consisted of borings used to determine 

the local soil stratigraphy. NWMI 

further stated that no other work was 

conducted at the site and that the 

University of Missouri continues to own 

the land, which remains undeveloped. 

II. License Termination 

Termination of licenses and permits 

issued under part 50 of title 10 of the 

Code of Federal Regulations (10 CFR) is 

governed by 10 CFR 50.82, 

‘‘Termination of license.’’ As discussed 

in ‘‘Current NRC Staff Views on 

Applying the Deferred Plant Policy 

Statement to Part 52 Plants,’’ the NRC 

staff does not apply the requirements for 

license termination in 10 CFR 50.82 to 

facilities that have not begun operation. 

Additionally, there was no construction 

associated with the NWMI RPF permit 

and nuclear materials were never 

procured or possessed under the permit. 

As such, with no radiological 

contamination associated with the 

permit, the RPF site may be released for 

unrestricted use pursuant to 10 CFR 

20.1402, ‘‘Radiological criteria for 

unrestricted use.’’ 

III. Environmental Review 

NWMI seeks to terminate the RPF 

permit for which construction never 

commenced and nuclear materials were 

never procured or brought on site. 

Terminating a construction permit is a 

licensing action that would ordinarily 

require an environmental assessment 

under 10 CFR 51.21, ‘‘Criteria for and 

identification of licensing and 

regulatory actions requiring 

environmental assessments,’’ unless a 

categorical exclusion in 10 CFR 51.22, 

‘‘Criterion for categorical exclusion; 

identification of licensing and 

regulatory actions eligible for categorical 

exclusion or otherwise not requiring 

environmental review,’’ paragraph (c) 

applies and no special circumstances 

under 10 CFR 51.22(b) exist. Actions 

listed in 10 CFR 51.22(c) were 

previously found by the Commission to 

be part of a category of actions that 

‘‘does not individually or cumulatively 

have a significant effect on the human 

environment.’’ 

The categorical exclusion identified 

in 10 CFR 51.22(c)(20) is: 

Decommissioning of sites where 

licensed operations have been limited to 

the use of— 

(i) Small quantities of short-lived 

radioactive materials; 

(ii) Radioactive materials in sealed 

sources, provided there is no evidence 

of leakage of radioactive material from 

these sealed sources; or 

(iii) Radioactive materials in such a 

manner that a decommissioning plan is 

not required by 10 CFR 30.36(g)(1), 

40.42(g)(1), or 70.38(g)(1) and the NRC 

has determined that the facility meets 

the radiological criteria for unrestricted 

use in 10 CFR 20.1402 without further 

remediation or analysis. 

This categorical exclusion 

encompasses decommissioning of sites 

where contamination from radioactive 

materials is determined to be nominal. 

In the case of the NWMI RPF, no 

associated radiological contamination 

exists because construction never 

commenced and nuclear material was 

never procured or brought on site. As a 

result, a decommissioning plan for this 

site is not required by subparagraph 

(g)(1) of 10 CFR 30.36, ‘‘Expiration and 

termination of licenses and 

decommissioning of sites and separate 

buildings or outdoor areas,’’ 

subparagraph (g)(1) of 10 CFR 40.42, 

‘‘Expiration and termination of licenses 

and decommissioning of sites and 

separate buildings or outdoor areas,’’ or 

subparagraph (g)(1) of 10 CFR 70.38, 

‘‘Expiration and termination of licenses 

and decommissioning of sites and 

separate buildings or outdoor areas,’’ 

and the site meets the radiological 

criteria for unrestricted use in 10 CFR 

20.1402 without further remediation or 

analysis. Further, no special 

circumstances under 10 CFR 51.22(b) 

exist. The factors listed in 10 CFR 

51.22(c)(20) are consistent with the 

circumstances here because there is no 

environmental impact associated with 

terminating the NWMI RPF permit, 

which is even less than the nominal 

impacts anticipated by the categorical 

exclusion. Therefore, application of the 

categorical exclusion to the termination 

of the NWMI RPF permit is warranted. 

Consequently, pursuant to 10 CFR 

51.22(b), no environmental impact 

statement or environmental assessment 

need be prepared in connection with the 

termination of Construction Permit No. 

CPMIF–002. 

IV. Availability of Documents 

The documents identified in the 

following table are available to 

interested persons through ADAMS, as 

indicated. 

Document ADAMS accession No. 

U.S. Nuclear Regulatory Commission, Northwest Medical Isotopes, LLC—Termination of Construction Permit No. CPMIF–002 

(EPID No. L–2022–LLL–0007), dated July 11, 2022.

ML22147A157 

Northwest Medical Isotopes, LLC, Request for Termination of Northwest Medical Isotopes, LLC (NWMI) Construction Permit 

No. CPMIF–002 (Docket No. 50–609), dated February 7, 2022.

ML22084A004 

U.S. Nuclear Regulatory Commission, Construction Permit No. CPMIF–002 for Northwest Medical Isotopes, LLC, Docket No. 

50–609, Medical Radioisotope Production Facility, dated May 9, 2018.

ML18037A468 

U.S. Nuclear Regulatory Commission, Current NRC Staff Views on Applying the Deferred Plant Policy Statement to Part 52 

Plants, dated March 6, 2018.

ML18065B257 

V. Conclusion 

As previously discussed, the 

Commission has determined that the 

NWMI RPF permit termination request 

meets the categorical exclusion criteria 

set forth in 10 CFR 51.22(c)(20) and that 

the unrestricted use criteria pursuant to 

10 CFR 20.1402 are met. 

The Commission grants NWMI’s 

request to terminate Construction 

Permit No. CPMIF–002. This license 

termination was effective upon NWMI’s 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 136 / Monday, July 18, 2022 / Notices 42753 

1 15 U.S.C. 80a. In addition, the offering and 

selling of securities that are not registered pursuant 

to the Securities Act of 1933 (‘‘Securities Act’’) is 

generally prohibited by U.S. securities laws. 15 

U.S.C. 77. 

2See Offer and Sale of Securities to Canadian 

Tax-Deferred Retirement Savings Accounts, Release 

Nos. 33–7860, 34–42905, IC–24491 (June 7, 2000) 

[65 FR 37672 (June 15, 2000)]. This rulemaking also 

included new rule 237 under the Securities Act, 

permitting securities of foreign issuers to be offered 

to Canadian-U.S. Participants and sold to Canadian 

retirement accounts without being registered under 

the Securities Act. 17 CFR 230.237. 

3 17 CFR 270.7d–2. 

4 44 U.S.C. 3501–3502. 

receipt of the NRC’s termination letter, 

dated July 11, 2022. 

Dated: July 13, 2022. 

For the Nuclear Regulatory Commission. 

Joshua M. Borromeo, 

Chief, Non-Power Production and Utilization 

Facility Licensing Branch, Division of 

Advanced Reactors and Non-Power 

Production and Utilization Facilities, Office 

of Nuclear Reactor Regulation. 

[FR Doc. 2022–15282 Filed 7–15–22; 8:45 am] 

BILLING CODE 7590–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

Sunshine Act Meetings 

TIME AND DATE: 2:00 p.m. on Thursday, 

July 21, 2022. 

PLACE: The meeting will be held via 

remote means and/or at the 

Commission’s headquarters, 100 F 

Street NE, Washington, DC 20549. 

STATUS: This meeting will be closed to 

the public. 

MATTERS TO BE CONSIDERED: 

Commissioners, Counsel to the 

Commissioners, the Secretary to the 

Commission, and recording secretaries 

will attend the closed meeting. Certain 

staff members who have an interest in 

the matters also may be present. 

In the event that the time, date, or 

location of this meeting changes, an 

announcement of the change, along with 

the new time, date, and/or place of the 

meeting will be posted on the 

Commission’s website at https://

www.sec.gov. 

The General Counsel of the 

Commission, or his designee, has 

certified that, in his opinion, one or 

more of the exemptions set forth in 5 

U.S.C. 552b(c)(3), (5), (6), (7), (8), 9(B) 

and (10) and 17 CFR 200.402(a)(3), 

(a)(5), (a)(6), (a)(7), (a)(8), (a)(9)(ii) and 

(a)(10), permit consideration of the 

scheduled matters at the closed meeting. 

The subject matter of the closed 

meeting will consist of the following 

topics: 

Institution and settlement of 

injunctive actions; 

Institution and settlement of 

administrative proceedings; 

Resolution of litigation claims; and 

Other matters relating to examinations 

and enforcement proceedings. 

At times, changes in Commission 

priorities require alterations in the 

scheduling of meeting agenda items that 

may consist of adjudicatory, 

examination, litigation, or regulatory 

matters. 

CONTACT PERSON FOR MORE INFORMATION: 

For further information; please contact 

Vanessa A. Countryman from the Office 

of the Secretary at (202) 551–5400. 

Authority: 5 U.S.C. 552b. 

Dated: July 14, 2022. 

Vanessa A. Countryman, 

Secretary. 

[FR Doc. 2022–15399 Filed 7–14–22; 4:15 pm] 

BILLING CODE 8011–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

[SEC File No. 270–464, OMB Control No. 

3235–0527] 

Submission for OMB Review; 

Comment Request; Extension: Rule 

7d–2 

Upon Written Request, Copies Available 

From: Securities and Exchange 

Commission, Office of FOIA Services, 

100 F Street NE, Washington, DC 

20549–2736 

Notice is hereby given that, pursuant 

to the Paperwork Reduction Act of 1995 

(44 U.S.C. 3501–3520), the Securities 

and Exchange Commission (the 

‘‘Commission’’) is soliciting comments 

on the collection of information 

summarized below. The Commission 

plans to submit this existing collection 

of information to the Office of 

Management and Budget for extension 

and approval. 

In Canada, as in the United States, 

individuals can invest a portion of their 

earnings in tax-deferred retirement 

savings accounts (‘‘Canadian retirement 

accounts’’). These accounts, which 

operate in a manner similar to 

individual retirement accounts in the 

United States, encourage retirement 

savings by permitting savings on a taxdeferred basis. Individuals who 

establish Canadian retirement accounts 

while living and working in Canada and 

who later move to the United States 

(‘‘Canadian-U.S. Participants’’ or 

‘‘participants’’) often continue to hold 

their retirement assets in their Canadian 

retirement accounts rather than 

prematurely withdrawing (or ‘‘cashing 

out’’) those assets, which would result 

in immediate taxation in Canada. 

Once in the United States, however, 

these participants historically have been 

unable to manage their Canadian 

retirement account investments. Most 

investment companies (‘‘funds’’) that 

are ‘‘qualified companies’’ for Canadian 

retirement accounts are not registered 

under the U.S. securities laws. 

Securities of those unregistered funds, 

therefore, generally cannot be publicly 

offered and sold in the United States 

without violating the registration 

requirement of the Investment Company 

Act of 1940 (‘‘Investment Company 

Act’’).1 As a result of this registration 

requirement, Canadian-U.S. Participants 

previously were not able to purchase or 

exchange securities for their Canadian 

retirement accounts as needed to meet 

their changing investment goals or 

income needs. 

The Commission issued a rulemaking 

in 2000 that enabled Canadian-U.S. 

Participants to manage the assets in 

their Canadian retirement accounts by 

providing relief from the U.S. 

registration requirements for offers of 

securities of foreign issuers to CanadianU.S. Participants and sales to Canadian 

retirement accounts.2 Rule 7d–2 under 

the Investment Company Act 3 permits 

foreign funds to offer securities to 

Canadian-U.S. Participants and sell 

securities to Canadian retirement 

accounts without registering as 

investment companies under the 

Investment Company Act. 

Rule 7d–2 contains a ‘‘collection of 

information’’ requirement within the 

meaning of the Paperwork Reduction 

Act of 1995.4 Rule 7d–2 requires written 

offering materials for securities offered 

or sold in reliance on that rule to 

disclose prominently that those 

securities and the fund issuing those 

securities are not registered with the 

Commission, and that those securities 

and the fund issuing those securities are 

exempt from registration under U.S. 

securities laws. Rule 7d–2 does not 

require any documents to be filed with 

the Commission. 

Rule 7d–2 requires written offering 

documents for securities offered or sold 

in reliance on the rule to disclose 

prominently that the securities are not 

registered with the Commission and 

may not be offered or sold in the United 

States unless registered or exempt from 

registration under the U.S. securities 

laws, and also to disclose prominently 

that the fund that issued the securities 

is not registered with the Commission. 

The burden under the rule associated 

with adding this disclosure to written 

offering documents is minimal and is 

non-recurring. The foreign issuer, 


khammond on DSKJM1Z7X2PROD with NOTICES